Author

Renea Taylor

Monash University - Cited by 4,421 - Prostate Cancer - Stem Cell Biology - Tumour Microenvironment - Urology

Biography

Dr Renea Taylor is a Senior Lecturer and Research Fellow in the Department of Physiology and Biomedicine Discovery Institute, Monash University. She graduated with a PhD in Reproductive Endocrinology in 2003 at Monash University and completed her postdoctoral training in Stem Cell Biology at the Monash Immunology and Stem Cell Laboratories. She pursued her research interest in hormone-dependent cancer, specialising in prostate cancer. The focus of her research program is the hormonal regulation of prostate stem cells and their interaction with the tumour microenvironment.
Title
Cited by
Year
Proteomic Profiling of Human Prostate Cancer-associated Fibroblasts (CAF) Reveals LOXL2-dependent Regulation of the Tumor Microenvironment*[S]
EV Nguyen, BA Pereira, MG Lawrence, X Ma, RJ Rebello, H Chan, ...Molecular & Cellular Proteomics 18 (7), 1410-1427, 2019201
68
2019
Breast cancer polygenic risk score and contralateral breast cancer risk
I Kramer, MJ Hooning, N Mavaddat, M Hauptmann, R Keeman, ...The American Journal of Human Genetics 107 (5), 837-848, 2020202
39
2020
The MURAL collection of prostate cancer patient-derived xenografts enables discovery through preclinical models of uro-oncology
GP Risbridger, AK Clark, LH Porter, R Toivanen, A Bakshi, NL Lister, ...Nature communications 12 (1), 5049, 2021202
31
2021
Post-transcriptional gene regulation by microRNA-194 promotes neuroendocrine transdifferentiation in prostate cancer
RC Fernandes, J Toubia, S Townley, AR Hanson, BK Dredge, KA Pillman, ...Cell reports 34 (1), 2021202
29
2021
Knowing what’s growing: why ductal and intraductal prostate cancer matter
MG Lawrence, LH Porter, D Clouston, DG Murphy, M Frydenberg, ...Science Translational Medicine 12 (533), eaaz0152, 2020202
24
2020
High-throughput imaging assay for drug screening of 3D prostate cancer organoids
N Choo, S Ramm, J Luu, JM Winter, LA Selth, AR Dwyer, M Frydenberg, ...SLAS DISCOVERY: Advancing the Science of Drug Discovery 26 (9), 1107-1124, 202
21
2021
PDX: moving beyond drug screening to versatile models for research discovery
GP Risbridger, MG Lawrence, RA TaylorJournal of the Endocrine Society 4 (11), bvaa132, 2020202
17
2020
Alterations in the methylome of the stromal tumour microenvironment signal the presence and severity of prostate cancer
MG Lawrence, R Pidsley, B Niranjan, M Papargiris, BA Pereira, ...Clinical Epigenetics 12 (1), 1-18, 2020202
17
2020
Chimeric antigen receptor T-cell therapy in metastatic castrate-resistant prostate cancer
MPJ Perera, PB Thomas, GP Risbridger, R Taylor, A Azad, MS Hofman, ...Cancers 14 (3), 503, 2022202
16
2022
Establishing a cryopreservation protocol for patient‐derived xenografts of prostate cancer
LH Porter, MG Lawrence, H Wang, AK Clark, A Bakshi, D Obinata, ...The Prostate 79 (11), 1326-1337, 2019201
15
2019
Proteome analysis of human adipocytes identifies depot-specific heterogeneity at metabolic control points
A Raajendiran, C Krisp, DPD Souza, G Ooi, PR Burton, RA Taylor, ...American Journal of Physiology-Endocrinology and Metabolism 320 (6), E1068-E1084, 2021202
14
2021
Androgen receptor enhancer amplification in matched patient‐derived xenografts of primary and castrate‐resistant prostate cancer
LH Porter, A Bakshi, D Pook, A Clark, D Clouston, J Kourambas, ...The Journal of pathology 254 (2), 121-134, 2021202
11
2021
Personalized medicine for prostate cancer: is targeting metabolism a reality?
G Fidelito, MJ Watt, RA TaylorFrontiers in Oncology 11, 5763, 2022202
10
2022
Neuroendocrine cells in prostate cancer correlate with poor outcomes: a systematic review and meta‐analysis
A Kannan, D Clouston, M Frydenberg, D Ilic, MN Karim, SM Evans, ...BJU international 130 (4), 420-433, 2022202
8
2022
Mast cell-derived SAMD14 is a novel regulator of the human prostate tumor microenvironment
LKH Teng, BA Pereira, S Keerthikumar, C Huang, B Niranjan, SN Lee, ...Cancers 13 (6), 1237, 2021202
8
2021
CX-5461 sensitizes DNA damage repair–proficient castrate-resistant prostate cancer to PARP inhibition
MG Lawrence, LH Porter, N Choo, D Pook, JP Grummet, CJ Pezaro, ...Molecular cancer therapeutics 20 (11), 2140-2150, 2021202
7
2021
Novel Therapeutic Targets and Biomarkers Associated with Prostate Cancer-Associated Fibroblasts (CAFs)
KC Clark, Y Wu, RA Taylor, RJ DalyCritical Reviews™ in Oncogenesis 2 (1), 2022202
7
2022
Unsuspected protumorigenic signaling role for the oncometabolite GABA in advanced prostate cancer
RA Taylor, MJ WattCancer Research 9 (18), 4580-4581, 2019201
7
2019
Early intervention exercise training does not delay prostate cancer progression in Pten−/− mice
RA Taylor, SG Farrelly, AK Clark, MJ WattThe Prostate 80 (11), 90-914, 2020202
6
2020
New approaches to targeting epigenetic regulation in prostate cancer
D Thompson, N Choo, DM Bolton, N Lawrentschuk, GP Risbridger, ...Current opinion in urology 32 (5), 72-80, 2022202
4
2022

Referred From: https://scholar.google.com/citations?user=hpxFnZUAAAAJ&hl=en&oi=ao

Cited by
Citations 4421
h-index 39
i10-index 72
Open Access Journals